<?xml version="1.0"?><rdf:RDF xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:edm="http://www.europeana.eu/schemas/edm/" xmlns:wgs84_pos="http://www.w3.org/2003/01/geo/wgs84_pos" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:rdaGr2="http://rdvocab.info/ElementsGr2" xmlns:oai="http://www.openarchives.org/OAI/2.0/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:ore="http://www.openarchives.org/ore/terms/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:dcterms="http://purl.org/dc/terms/"><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-U3KLM3CN/f4128771-9603-48c5-a386-084274b82fa8/HTML"><dcterms:extent>14 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-U3KLM3CN/62a35cf0-204d-4a2a-aa81-bd54439dbc38/PDF"><dcterms:extent>44 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-U3KLM3CN/e35372ae-803c-416b-8c59-d2425b782c25/TEXT"><dcterms:extent>12 KB</dcterms:extent></edm:WebResource><edm:TimeSpan rdf:about="1929-2026"><edm:begin xml:lang="en">1929</edm:begin><edm:end xml:lang="en">2026</edm:end></edm:TimeSpan><edm:ProvidedCHO rdf:about="URN:NBN:SI:doc-U3KLM3CN"><dcterms:isPartOf rdf:resource="https://www.dlib.si/details/urn:nbn:si:spr-a30mfzkp" /><dcterms:issued>2001</dcterms:issued><dc:creator>Terzič, Dragan</dc:creator><dc:format xml:lang="sl">številka:7/8</dc:format><dc:format xml:lang="sl">letnik:70</dc:format><dc:format xml:lang="sl">str. 415-417</dc:format><dc:identifier>ISSN:1318-0347</dc:identifier><dc:identifier>COBISSID:13644505</dc:identifier><dc:identifier>URN:URN:NBN:SI:doc-U3KLM3CN</dc:identifier><dc:language>sl</dc:language><dc:publisher xml:lang="sl">Slovensko zdravniško društvo</dc:publisher><dcterms:isPartOf xml:lang="sl">Zdravniški vestnik</dcterms:isPartOf><dc:subject xml:lang="en">Cholinesterase inhibitors</dc:subject><dc:subject xml:lang="sl">depresija (medicina)</dc:subject><dc:subject xml:lang="en">Depressive disorder</dc:subject><dc:subject xml:lang="en">Drug resistance</dc:subject><dc:subject xml:lang="en">Drug therapy</dc:subject><dc:subject xml:lang="en">therapy</dc:subject><dc:subject xml:lang="sl">zdravljenje</dc:subject><dcterms:temporal rdf:resource="1929-2026" /><dc:title xml:lang="sl">Zdravljenje rezistentnih depresij in primer uspešne uporabe donepezil HCl v njihovi obravnavi| Treatment od resistant depressions and case of successful use of donepezil HClin their therapy|</dc:title><dc:description xml:lang="sl">Background. In this article some approaches how to treat a stadium of resistant depression are described. There is aslo a description of the successful use of inhibitors acetylholinesterase donepezil hydrochloride (Aricept) in treatment of this kind of depression. Taking into account a greatnumber of depressive patients who are resistant to usual antidepressivs these new approaches to treatment are of a great importance due to the fact that in many cases previous treatments of a depressive patients proved to be unsuccessful. This article is considered to be one of the first description inrespect of the use of inhibitors of acetylcholinesterase in treatment of resistant depressions. Conclusions. In case of resistant depressions one of the possibilities of its treatment is the use of inhibitors of acetylcholinesterase (and may be others) in combination with antidepressants</dc:description><dc:description xml:lang="sl">Izhodišča. V pričujočem članku so opisane možnosti zdravljenja rezistentnih depresij in primer uspešne uporabe inhibitorja acetilholinesteraze donepezil hidroklorida (Aricept) v njihovi uporabi. Glede na veliko število depresivnih bolnikov, rezistentnih na antidepresive, so novi pristopi za zdravljenje omenjene oblike bolezni velikega pomena, saj je kljub številnim možnostim veliko število bolnikov neuspešno zdravljenih. To je eden od prvih opisov uporabe inhibitorjev acetilholinesteraze v zdravljenju rezistentnih depresij. Zaključki. V primeru rezistentnih depresij je ena izmed možnosti uporaba inhibitorjev acetilholinesteraze donepezila HCI (in morda drugih) v kombinaciji z antidepresivi</dc:description><edm:type>TEXT</edm:type><dc:type xml:lang="sl">znanstveno časopisje</dc:type><dc:type xml:lang="en">journals</dc:type><dc:type rdf:resource="http://www.wikidata.org/entity/Q361785" /></edm:ProvidedCHO><ore:Aggregation rdf:about="http://www.dlib.si/?URN=URN:NBN:SI:doc-U3KLM3CN"><edm:aggregatedCHO rdf:resource="URN:NBN:SI:doc-U3KLM3CN" /><edm:isShownBy rdf:resource="http://www.dlib.si/stream/URN:NBN:SI:doc-U3KLM3CN/62a35cf0-204d-4a2a-aa81-bd54439dbc38/PDF" /><edm:rights rdf:resource="http://creativecommons.org/licenses/by-nc/4.0/" /><edm:provider>Slovenian National E-content Aggregator</edm:provider><edm:intermediateProvider xml:lang="en">National and University Library of Slovenia</edm:intermediateProvider><edm:dataProvider xml:lang="sl">Slovensko zdravniško društvo</edm:dataProvider><edm:object rdf:resource="http://www.dlib.si/streamdb/URN:NBN:SI:doc-U3KLM3CN/maxi/edm" /><edm:isShownAt rdf:resource="http://www.dlib.si/details/URN:NBN:SI:doc-U3KLM3CN" /></ore:Aggregation></rdf:RDF>